Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trials

Larissa A. de Lucena,Marcos A. A. Freitas,Ana K. C. Souza,Caroliny H. A. Silva,Janine M. F. Watanabe,Felipe L. Guedes,Jose B. Almeida,Rodrigo A. de Oliveira
DOI: https://doi.org/10.1007/s11239-023-02945-0
2024-01-29
Journal of Thrombosis and Thrombolysis
Abstract:In patients with atrial fibrillation (AF) and normal or slightly impaired renal function, the use of direct oral anticoagulants (DOACs) is preferable to vitamin K antagonists (VKAs). However, in patients undergoing hemodialysis, the efficacy, and safety of DOACs compared with VKAs are still unknown.
cardiac & cardiovascular systems,peripheral vascular disease,hematology
What problem does this paper attempt to address?